For patients with cervical cancer that has recurred after treatment or has spread elsewhere in the body, adding the experimental drug cediranib to standard chemotherapy improves tumor shrinkage and adds a modest improvement in progression-free survival, researchers report.

Source: Adding cediranib to chemotherapy im...nt cervical cancer, phase II trial shows


David Cottle

UBB Owner & Administrator